 | • レポートコード：MRC2-11QY11364 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性腎臓病（CKD）のグローバル市場について調査・分析したレポートです。種類別（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性腎臓病（CKD）の競争状況、市場シェア ・世界の慢性腎臓病（CKD）市場：種類別市場規模 2015年-2020年（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他） ・世界の慢性腎臓病（CKD）市場：種類別市場規模予測 2021年-2026年（ACE阻害薬、カルシウム拮抗薬、ベータ遮断薬、その他） ・世界の慢性腎臓病（CKD）市場：用途別市場規模 2015年-2020年（病院、専門クリニック） ・世界の慢性腎臓病（CKD）市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック） ・北米の慢性腎臓病（CKD）市場分析：米国、カナダ ・ヨーロッパの慢性腎臓病（CKD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性腎臓病（CKD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性腎臓病（CKD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性腎臓病（CKD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Allergan、Amgen、AstraZeneca、Roche、FibroGen、GlaxoSmithKline、Johnson & Johnson、Keryx、Kissei、Pfizer、Sanofi、Teva ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market
The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chronic Kidney Disease (CKD) Scope and Market Size
Chronic Kidney Disease (CKD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease (CKD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva
Market segment by Type, the product can be split into
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Market segment by Application, split into
Hospitals
Specialty Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ACE Inhibitors
1.4.3 Calcium Channel Blockers
1.4.4 Beta Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease (CKD) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chronic Kidney Disease (CKD) Market Perspective (2015-2026)
2.2 Global Chronic Kidney Disease (CKD) Growth Trends by Regions
2.2.1 Chronic Kidney Disease (CKD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Kidney Disease (CKD) Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Kidney Disease (CKD) Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Kidney Disease (CKD) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chronic Kidney Disease (CKD) Players by Market Size
3.1.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue (2015-2020)
3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Kidney Disease (CKD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Kidney Disease (CKD) Market Concentration Ratio
3.2.1 Global Chronic Kidney Disease (CKD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Revenue in 2019
3.3 Chronic Kidney Disease (CKD) Key Players Head office and Area Served
3.4 Key Players Chronic Kidney Disease (CKD) Product Solution and Service
3.5 Date of Enter into Chronic Kidney Disease (CKD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2015-2020)
4.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
5.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Kidney Disease (CKD) Market Size (2015-2020)
6.2 Chronic Kidney Disease (CKD) Key Players in North America (2019-2020)
6.3 North America Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
6.4 North America Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Market Size (2015-2020)
7.2 Chronic Kidney Disease (CKD) Key Players in Europe (2019-2020)
7.3 Europe Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
7.4 Europe Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
8 China
8.1 China Chronic Kidney Disease (CKD) Market Size (2015-2020)
8.2 Chronic Kidney Disease (CKD) Key Players in China (2019-2020)
8.3 China Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
8.4 China Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chronic Kidney Disease (CKD) Market Size (2015-2020)
9.2 Chronic Kidney Disease (CKD) Key Players in Japan (2019-2020)
9.3 Japan Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
9.4 Japan Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chronic Kidney Disease (CKD) Market Size (2015-2020)
10.2 Chronic Kidney Disease (CKD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
11 India
11.1 India Chronic Kidney Disease (CKD) Market Size (2015-2020)
11.2 Chronic Kidney Disease (CKD) Key Players in India (2019-2020)
11.3 India Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
11.4 India Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chronic Kidney Disease (CKD) Market Size (2015-2020)
12.2 Chronic Kidney Disease (CKD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
12.4 Central & South America Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction
13.1.4 AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Chronic Kidney Disease (CKD) Introduction
13.2.4 Allergan Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Chronic Kidney Disease (CKD) Introduction
13.3.4 Amgen Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction
13.4.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Chronic Kidney Disease (CKD) Introduction
13.5.4 Roche Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.5.5 Roche Recent Development
13.6 FibroGen
13.6.1 FibroGen Company Details
13.6.2 FibroGen Business Overview
13.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction
13.6.4 FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.6.5 FibroGen Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview
13.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction
13.7.4 GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview
13.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction
13.8.4 Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 Keryx
13.9.1 Keryx Company Details
13.9.2 Keryx Business Overview
13.9.3 Keryx Chronic Kidney Disease (CKD) Introduction
13.9.4 Keryx Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.9.5 Keryx Recent Development
13.10 Kissei
13.10.1 Kissei Company Details
13.10.2 Kissei Business Overview
13.10.3 Kissei Chronic Kidney Disease (CKD) Introduction
13.10.4 Kissei Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
13.10.5 Kissei Recent Development
13.11 Pfizer
10.11.1 Pfizer Company Details
10.11.2 Pfizer Business Overview
10.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction
10.11.4 Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
10.11.5 Pfizer Recent Development
13.12 Sanofi
10.12.1 Sanofi Company Details
10.12.2 Sanofi Business Overview
10.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction
10.12.4 Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
10.12.5 Sanofi Recent Development
13.13 Teva
10.13.1 Teva Company Details
10.13.2 Teva Business Overview
10.13.3 Teva Chronic Kidney Disease (CKD) Introduction
10.13.4 Teva Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
10.13.5 Teva Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chronic Kidney Disease (CKD) Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Kidney Disease (CKD) Revenue
Table 3. Ranking of Global Top Chronic Kidney Disease (CKD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ACE Inhibitors
Table 6. Key Players of Calcium Channel Blockers
Table 7. Key Players of Beta Blockers
Table 8. Key Players of Others
Table 9. Global Chronic Kidney Disease (CKD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Chronic Kidney Disease (CKD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Chronic Kidney Disease (CKD) Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Chronic Kidney Disease (CKD) Market Share by Regions (2015-2020)
Table 13. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Chronic Kidney Disease (CKD) Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Chronic Kidney Disease (CKD) Market Growth Strategy
Table 19. Main Points Interviewed from Key Chronic Kidney Disease (CKD) Players
Table 20. Global Chronic Kidney Disease (CKD) Revenue by Players (2015-2020) (Million US$)
Table 21. Global Chronic Kidney Disease (CKD) Market Share by Players (2015-2020)
Table 22. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) as of 2019)
Table 23. Global Chronic Kidney Disease (CKD) by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chronic Kidney Disease (CKD) Product Solution and Service
Table 26. Date of Enter into Chronic Kidney Disease (CKD) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 29. Global Chronic Kidney Disease (CKD) Market Size Share by Type (2015-2020)
Table 30. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2021-2026)
Table 31. Global Chronic Kidney Disease (CKD) Market Size Share by Application (2015-2020)
Table 32. Global Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 33. Global Chronic Kidney Disease (CKD) Market Size Share by Application (2021-2026)
Table 34. North America Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 36. North America Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 37. North America Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 38. North America Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 39. North America Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 40. Europe Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 42. Europe Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 44. Europe Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 46. China Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 47. China Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 48. China Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 49. China Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 50. China Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 51. China Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 52. Japan Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 54. Japan Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 56. Japan Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 60. Southeast Asia Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 62. Southeast Asia Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 64. India Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 65. India Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 66. India Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 67. India Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 68. India Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 69. India Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Chronic Kidney Disease (CKD) Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Chronic Kidney Disease (CKD) Market Share (2019-2020)
Table 72. Central & South America Chronic Kidney Disease (CKD) Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Chronic Kidney Disease (CKD) Market Share by Type (2015-2020)
Table 74. Central & South America Chronic Kidney Disease (CKD) Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Chronic Kidney Disease (CKD) Market Share by Application (2015-2020)
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Allergan Company Details
Table 82. Allergan Business Overview
Table 83. Allergan Product
Table 84. Allergan Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 85. Allergan Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Product
Table 89. Amgen Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 90. Amgen Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 95. AstraZeneca Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. FibroGen Company Details
Table 102. FibroGen Business Overview
Table 103. FibroGen Product
Table 104. FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 105. FibroGen Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Product
Table 109. GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 110. GlaxoSmithKline Recent Development
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Product
Table 113. Johnson & Johnson Company Details
Table 114. Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 115. Johnson & Johnson Recent Development
Table 116. Keryx Company Details
Table 117. Keryx Business Overview
Table 118. Keryx Product
Table 119. Keryx Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 120. Keryx Recent Development
Table 121. Kissei Company Details
Table 122. Kissei Business Overview
Table 123. Kissei Product
Table 124. Kissei Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 125. Kissei Recent Development
Table 126. Pfizer Company Details
Table 127. Pfizer Business Overview
Table 128. Pfizer Product
Table 129. Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 130. Pfizer Recent Development
Table 131. Sanofi Company Details
Table 132. Sanofi Business Overview
Table 133. Sanofi Product
Table 134. Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 135. Sanofi Recent Development
Table 136. Teva Company Details
Table 137. Teva Business Overview
Table 138. Teva Product
Table 139. Teva Revenue in Chronic Kidney Disease (CKD) Business (2015-2020) (Million US$)
Table 140. Teva Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Kidney Disease (CKD) Market Share by Type: 2020 VS 2026
Figure 2. ACE Inhibitors Features
Figure 3. Calcium Channel Blockers Features
Figure 4. Beta Blockers Features
Figure 5. Others Features
Figure 6. Global Chronic Kidney Disease (CKD) Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Chronic Kidney Disease (CKD) Report Years Considered
Figure 10. Global Chronic Kidney Disease (CKD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Chronic Kidney Disease (CKD) Market Share by Regions: 2020 VS 2026
Figure 12. Global Chronic Kidney Disease (CKD) Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Chronic Kidney Disease (CKD) Market Share by Players in 2019
Figure 15. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease (CKD) as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2019
Figure 17. North America Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Chronic Kidney Disease (CKD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
慢性閉塞性肺疾患（COPD）の世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…- 末期腎疾患治療の世界市場（～2026年） Market Analysis and Insights: Global End-Stage Kidney Disease Treatment Market The global End-Stage Kidney Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global End-Stage Kidney Disease Treatment Scope and …
- 慢性閉塞性肺疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Treatment Market The global Chronic Obstructive Pulmonary Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Obstructive…
- 冠動脈疾患治療薬の世界市場（～2026年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…
- 腎疾患の世界市場（～2026年） Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Considering the global scenario of the market, North America is believed to be the largest market f…